These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Risk of pneumonia in new users of cholinesterase inhibitors for dementia. Lai EC; Wong MB; Iwata I; Zhang Y; Hsieh CY; Kao Yang YH; Setoguchi S J Am Geriatr Soc; 2015 May; 63(5):869-76. PubMed ID: 25912671 [TBL] [Abstract][Full Text] [Related]
23. A controlled, longitudinal study of dementia in Parkinson's disease. Biggins CA; Boyd JL; Harrop FM; Madeley P; Mindham RH; Randall JI; Spokes EG J Neurol Neurosurg Psychiatry; 1992 Jul; 55(7):566-71. PubMed ID: 1640232 [TBL] [Abstract][Full Text] [Related]
24. A population-based study of dosing and persistence with anti-dementia medications. Brewer L; Bennett K; McGreevy C; Williams D Eur J Clin Pharmacol; 2013 Jul; 69(7):1467-75. PubMed ID: 23443628 [TBL] [Abstract][Full Text] [Related]
25. Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. Ravina B; Putt M; Siderowf A; Farrar JT; Gillespie M; Crawley A; Fernandez HH; Trieschmann MM; Reichwein S; Simuni T J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):934-9. PubMed ID: 15965198 [TBL] [Abstract][Full Text] [Related]
26. Independent effect of cardiometabolic syndromes and depression on dementia in Parkinson's disease: A 12-year longitudinal follow-up study of a nationwide cohort. Kang SH; Choi Y; Chung SJ; Kim CK; Kim JH; Oh K; Yoon JS; Cho GJ; Koh SB Eur J Neurol; 2023 Apr; 30(4):911-919. PubMed ID: 36692249 [TBL] [Abstract][Full Text] [Related]
27. [Patterns of antidemential drug use in a group of patients from Colombia]. Calvo-Torres LF; Bernal-Cobo R; Trujillo-Quintero PM; Gaviria-Mendoza A; Machado-Alba JE Rev Neurol; 2019 May; 68(10):409-416. PubMed ID: 31070232 [TBL] [Abstract][Full Text] [Related]
28. The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil. Müller T; Welnic J; Fuchs G; Baas H; Ebersbach G; Reichmann H J Neural Transm Suppl; 2006; (71):27-30. PubMed ID: 17447412 [TBL] [Abstract][Full Text] [Related]
30. Clinical Association between Gout and Parkinson's Disease: A Nationwide Population-Based Cohort Study in Korea. Kim JH; Choi IA; Kim A; Kang G Medicina (Kaunas); 2021 Nov; 57(12):. PubMed ID: 34946237 [No Abstract] [Full Text] [Related]
31. Prevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea. Han S; Kim S; Kim H; Shin HW; Na KS; Suh HS BMC Public Health; 2019 Oct; 19(1):1328. PubMed ID: 31640652 [TBL] [Abstract][Full Text] [Related]
32. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis. Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262 [TBL] [Abstract][Full Text] [Related]
33. Real-world pharmacological treatment patterns of patients with young-onset Parkinson's disease in Japan: a medical claims database analysis. Kasamo S; Takeuchi M; Ikuno M; Kawasaki Y; Tanaka S; Takahashi R; Kawakami K J Neurol; 2019 Aug; 266(8):1944-1952. PubMed ID: 31076875 [TBL] [Abstract][Full Text] [Related]
34. Association Between Burning Mouth Syndrome and the Development of Depression, Anxiety, Dementia, and Parkinson Disease. Kim JY; Kim YS; Ko I; Kim DK JAMA Otolaryngol Head Neck Surg; 2020 Jun; 146(6):561-569. PubMed ID: 32352482 [TBL] [Abstract][Full Text] [Related]
35. Dementia in Parkinson's disease: Is male gender a risk factor? Cereda E; Cilia R; Klersy C; Siri C; Pozzi B; Reali E; Colombo A; Zecchinelli AL; Mariani CB; Tesei S; Canesi M; Sacilotto G; Meucci N; Zini M; Isaias IU; Barichella M; Cassani E; Goldwurm S; Pezzoli G Parkinsonism Relat Disord; 2016 May; 26():67-72. PubMed ID: 26952697 [TBL] [Abstract][Full Text] [Related]
36. Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions. Mollenhauer B; Förstl H; Deuschl G; Storch A; Oertel W; Trenkwalder C Dtsch Arztebl Int; 2010 Oct; 107(39):684-91. PubMed ID: 20963199 [TBL] [Abstract][Full Text] [Related]
37. One-Year Persistence with Donepezil, Memantine, and Rivastigmine in More than 66,000 Elderly Patients Followed in Poland. Kostev K; Kurylo P; Kosik J; Jacob L J Alzheimers Dis; 2019; 70(3):899-905. PubMed ID: 31306136 [TBL] [Abstract][Full Text] [Related]
38. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Battle CE; Abdul-Rahim AH; Shenkin SD; Hewitt J; Quinn TJ Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013306. PubMed ID: 33704781 [TBL] [Abstract][Full Text] [Related]
39. Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study. Scharre DW; Vekeman F; Lefebvre P; Mody-Patel N; Kahler KH; Duh MS Drugs Aging; 2010 Nov; 27(11):903-13. PubMed ID: 20964464 [TBL] [Abstract][Full Text] [Related]
40. Dysphagia Requiring Medical Attention in Parkinson's Disease: A Korean Population-Based Study. Cha S; Chang WK; Cho HM; Han K; Paik NJ; Kwon S; Kim WS J Korean Med Sci; 2023 Apr; 38(15):e114. PubMed ID: 37069809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]